Business Description
Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Beef, Pork, Chicken, and Prepared Foods. The company processes live fed cattle and live market hogs; fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully cooked meats; raises and processes chickens into fresh, frozen, and value-added chicken products; and supplies poultry breeding stock; sells specialty products, such as hides and meats. It also manufactures and markets frozen and refrigerated food products, including ready-to-eat sandwiches, flame-grilled hamburgers, Philly steaks, pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, flour and corn tortilla products, appetizers, snacks, prepared meals, ethnic foods, side dishes, meat dishes, breadsticks, and processed meats under the Jimmy Dean, Hillshire Farm, Ball Park, Wright, State Fair, Aidells, and Gallo Salame brands. The company also offers its products under Tyson and ibp brands. It sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors who serve restaurants and food service operations, such as plant and school cafeterias, convenience stores, hospitals, and other vendors, as well as through independent brokers and trading companies. The company was founded in 1935 and is headquartered in Springdale, Arkansas.
Business History
Generated: Jun 7, 2026 5:17pmPrice Overview
Last updated: Jun 7, 2026 5:14pm (19d ago)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 1.36
Total Equity: $18.09B
Shares: 348,000,000
Total Debt: $8.83B
Cash: $1.23B
EBITDA: $2.58B
Total Debt: $8.83B
Cash: $1.23B
Revenue: $54.44B
Revenue: $54.44B
Revenue: $54.44B
Total Equity: $18.09B
Tax Rate: 34.1%
Equity: $18.09B
Total Debt: $8.83B
Cash: $1.23B
Current Liabilities: $6.39B
Long-Term Debt: $7.92B
Total Debt: $8.83B
Total Equity: $18.09B
Shares: 348,000,000
Shares: 348,000,000
CapEx: -$978.00M
Shares: 348,000,000
Stock Price: $58.73
Net Income: $474.00M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 7, 2026 5:20pm (19d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $47.0B | $53.3B | $52.9B | $53.3B | $54.4B |
| Cost of Revenue | $40.5B | $46.6B | $50.3B | $49.7B | $50.9B |
| Gross Profit | $6.5B | $6.7B | $2.6B | $3.6B | $3.6B |
| Operating Expenses | $2.1B | $2.3B | $3.0B | $2.2B | $2.1B |
| Operating Income | $4.4B | $4.4B | -$395.0M | $1.4B | $1.4B |
| Net Income | $3.0B | $3.2B | -$648.0M | $800.0M | $474.0M |
| EBITDA | $5.7B | $5.7B | $1.0B | $3.0B | $2.6B |
| EPS | $8.57 | $9.18 | $-1.87 | $2.31 | $1.36 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 7, 2026 5:15pm (19d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2.5B | $1.0B | $573.0M | $1.7B | $1.2B |
| Total Current Assets | $9.8B | $9.6B | $8.7B | $9.8B | $9.9B |
| Total Assets | $36.3B | $36.8B | $36.3B | $37.1B | $36.7B |
| Current Liabilities | $6.3B | $5.3B | $6.5B | $4.8B | $6.4B |
| Long-Term Debt | $8.3B | $7.9B | $7.6B | $9.7B | $7.9B |
| Total Liabilities | $18.5B | $17.0B | $18.0B | $18.6B | $18.4B |
| Total Equity | $17.7B | $19.7B | $18.1B | $18.4B | $18.1B |
| Retained Earnings | $17.5B | $20.1B | $18.8B | $18.9B | $18.6B |
Cash Flow (Annual)
Last updated: Jun 7, 2026 5:20pm (19d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3.8B | $2.7B | $1.8B | $2.6B | $2.2B |
| Capital Expenditure | -$1.2B | -$1.9B | -$1.9B | -$1.1B | -$978.0M |
| Free Cash Flow | $2.6B | $800.0M | -$187.0M | $1.5B | $1.2B |
| Acquisitions (net) | $1.1B | -$177.0M | -$377.0M | $145.0M | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$67.0M | -$702.0M | -$354.0M | -$49.0M | -$196.0M |
| Net Change in Cash | $1.2B | -$1.6B | -$458.0M | $1.1B | -$488.0M |
Analyst Estimates (Annual)
Last updated: Jun 7, 2026 5:14pm (19d ago)| Metric | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| Revenue |
$56.5B $55.8B – $57.1B
|
$56.9B $56.1B – $57.5B
|
$58.2B $58.2B – $58.2B
|
$60.7B $59.9B – $61.5B
|
| EBITDA |
$4.0B $3.9B – $4.0B
|
$4.0B $3.9B – $4.0B
|
$4.1B $4.1B – $4.1B
|
$4.3B $4.2B – $4.3B
|
| Net Income |
$1.4B $1.4B – $1.5B
|
$1.6B $1.4B – $1.7B
|
$2.0B $2.0B – $2.0B
|
$2.3B $2.3B – $2.3B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 7, 2026 5:20pm (19d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +13.2% | -0.8% | +0.8% | +2.1% |
| Gross Profit Growth | +2.2% | -60.5% | +37.9% | -1.8% |
| Operating Income Growth | +0.3% | -109.0% | +456.7% | +2.3% |
| Net Income Growth | +6.3% | -120.0% | +223.5% | -40.8% |
| EBITDA Growth | +0.6% | -82.2% | +192.6% | -13.3% |
Insider Trading (Recent)
Last updated: Jun 7, 2026 5:19pm (19d ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-15 | MORRIS WES | 0.00 | $0.00 | $0 | |
| 2026-06-15 | MORRIS WES | 28,876.44 | $0.00 | $0 | |
| 2025-11-18 | MORRIS WES | 59,183.00 | $64.54 | $3.8M | |
| 2024-11-17 | MORRIS WES | 22,065.00 | $48.74 | $1.1M | |
| 2025-12-23 | COLE DEVIN | J-Other | 24,923.00 | $0.00 | $0 |
| 2026-05-09 | COLE DEVIN | F-InKind | 766.00 | $68.38 | $52,379 |
| 2026-05-10 | COLE DEVIN | F-InKind | 7,510.00 | $68.38 | $513,534 |
| 2026-05-10 | COLE DEVIN | F-InKind | 3,015.00 | $68.38 | $206,166 |
| 2026-04-06 | Thomas Phillip W | 0.00 | $0.00 | $0 | |
| 2026-04-06 | Thomas Phillip W | 765.66 | $0.00 | $0 | |
| 2024-11-17 | Thomas Phillip W | 3,862.00 | $48.74 | $188,234 | |
| 2019-11-19 | Thomas Phillip W | 3,855.00 | $59.42 | $229,064 | |
| 2017-11-28 | Thomas Phillip W | 2,261.00 | $58.34 | $131,907 | |
| 2018-11-17 | Thomas Phillip W | 2,400.00 | $77.97 | $187,128 | |
| 2020-11-18 | Thomas Phillip W | 2,611.00 | $89.98 | $234,938 | |
| 2021-11-20 | Thomas Phillip W | 3,910.00 | $60.74 | $237,493 | |
| 2022-11-19 | Thomas Phillip W | 2,647.00 | $81.51 | $215,757 | |
| 2023-11-18 | Thomas Phillip W | 2,766.00 | $65.52 | $181,228 | |
| 2025-11-18 | Thomas Phillip W | 3,139.00 | $64.54 | $202,591 | |
| 2026-02-09 | HANSON JACQUELINE | F-InKind | 1,925.00 | $65.40 | $125,895 |
Dividend History (Last 20)
Last updated: Jun 7, 2026 5:14pm (19d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-09-01 | $0.51 | 2026-05-07 | 2026-09-01 | 2026-09-15 |
| 2026-06-01 | $0.51 | 2026-02-04 | 2026-06-01 | 2026-06-15 |
| 2026-02-27 | $0.51 | 2025-11-07 | 2026-02-27 | 2026-03-13 |
| 2025-12-01 | $0.51 | 2025-08-07 | 2025-12-01 | 2025-12-15 |
| 2025-08-29 | $0.50 | 2025-05-09 | 2025-08-29 | 2025-09-12 |
| 2025-05-30 | $0.50 | 2025-02-06 | 2025-05-30 | 2025-06-13 |
| 2025-02-28 | $0.50 | 2024-11-08 | 2025-02-28 | 2025-03-14 |
| 2024-11-29 | $0.50 | 2024-08-08 | 2024-11-29 | 2024-12-13 |
| 2024-08-30 | $0.49 | 2024-05-09 | 2024-08-30 | 2024-09-13 |
| 2024-05-31 | $0.49 | 2024-02-08 | 2024-05-31 | 2024-06-14 |
| 2024-02-29 | $0.49 | 2023-11-10 | 2024-03-01 | 2024-03-15 |
| 2023-11-30 | $0.49 | 2023-08-10 | 2023-12-01 | 2023-12-15 |
| 2023-08-31 | $0.48 | 2023-05-11 | 2023-09-01 | 2023-09-15 |
| 2023-05-31 | $0.48 | 2023-02-09 | 2023-06-01 | 2023-06-15 |
| 2023-02-28 | $0.48 | 2022-11-14 | 2023-03-01 | 2023-03-15 |
| 2022-11-30 | $0.46 | 2022-08-11 | 2022-12-01 | 2022-12-15 |
| 2022-08-31 | $0.46 | 2022-05-23 | 2022-09-01 | 2022-09-15 |
| 2022-05-31 | $0.46 | 2022-02-09 | 2022-06-01 | 2022-06-15 |
| 2022-02-28 | $0.46 | 2021-11-12 | 2022-03-01 | 2022-03-15 |
| 2021-11-30 | $0.46 | 2021-11-12 | 2021-12-01 | 2021-12-15 |
Narrative Economics
market-narrative step).
Delvantic AI Findings
Looking at the raw quarterly trajectory first: revenue is flat-to-slightly-up ($13.35B → $13.65B over seven quarters, ~2% YoY), but the net income story is more interesting than the synthesis suggests. The most recent quarter (March 2026) shows $260M NI at 1.9% margin — a sharp recovery from the $7M / $47M / $61M / $85M wasteland of the prior four quarters. That's a 4x sequential jump. Either this is the cyclical inflection bulls have been waiting for (beef cycle turning, chicken margins normalizing) or it's a one-quarter headfake driven by feed cost timing. The synthesis verdict of "fair value $19-22" against a $58.73 price implies a 67% downside — that's an extraordinary claim that requires extraordinary evidence, and I don't see it in the data.
The DCF-driven $21.94 fair value looks mechanically derived from depressed TTM earnings ($474M annual NI on a $20.9B market cap = 44x P/E). But this is precisely the wrong moment in a commodity cycle to capitalize trough earnings. Normalize to the 2021-2022 average ($3.1B NI) and you get a ~7x P/E at current price — cheap. Even half-normalized at $1.5B NI gets you ~14x, reasonable for a defensive dividend payer yielding 3.7%. EV/EBITDA of 11.2x and P/S of 0.35x are not "67% overvalued" metrics for a protein processor; they're middle-of-the-range. The Market Forces claim of "losing 8% market share annually" is not supported by anything in this file — Tyson's revenue is flat, not collapsing, and they remain the dominant US protein processor. That signal looks like narrative overreach.
Where I'd push back on my own bullishness: the balance sheet section is blanked out (no debt figure, no equity figure), which is a real gap given the synthesis flagged "high debt risk — interest coverage dangerously low." Tyson carried roughly $9B in long-term debt historically; on $1.44B operating income, coverage is thin but not catastrophic, and $2.16B operating cash flow / $1.18B FCF comfortably funds the ~$525M dividend. The insider activity is uninformative — small F-InKind tax withholdings, no open-market buying conviction signal either way. The fallen-angel narrative read is correct: there's no growth story here, and you're being paid 3.7% to wait through a cycle. The alt-protein "disruption" bear thesis has been wrong for five years and Beyond Meat is a $400M market cap rounding error; that risk is overstated.
I dissent from the synthesis verdict. A $19 fair value on TSN requires believing protein consumption is in secular decline AND that Tyson loses pricing power permanently AND that the Q1 2026 margin recovery reverses — three independent bearish assumptions stacked. The more defensible read: TSN is a cyclical trough play where normalized earnings power is $2.50-3.50 EPS, fair value sits in the $50-65 range at 18-20x mid-cycle, and you collect 3.7% while waiting. The Q1 2026 print at 1.9% margin is the first real evidence of inflection in two years and deserves weight the synthesis didn't give it. Risk is that Q2 reverts — if the next print drops back to sub-1% margins, the cycle call is wrong and $45-50 becomes the floor. Pre-flight's $4.50 normalized EPS at 13x = $58 actually triangulates close to spot price, which is the most honest read in the file.
GPT Critique
In reviewing the raw data for Tyson Foods, Inc., a few aspects capture my attention. The revenue trend exhibits a stable but unimpressive growth trajectory, with recent quarters slightly up from $13.35B to $13.65B over seven quarters. However, the net income reveals a more volatile story, swinging from a low of $7M to a recent $260M, reflecting a recovery in net margin to 1.9%. This suggests potential cyclical recovery, but margins remain significantly below historical highs of 8-10%. The valuation metrics present a mixed picture: a P/E ratio of 45.8 suggests overvaluation, yet a P/S ratio of 0.35 and EV/EBITDA of 11.2 do not scream excessive pricing for a commodity processor. Cash flow remains robust, with operating cash flow at $2.16B and free cash flow at $1.18B, supporting its dividend yield of 3.7%.
Opus argues that the synthesis verdict of a $21.94 fair value is flawed due to capitalizing trough earnings, and I concur. The suggestion of a 67% downside from the current $58.73 price lacks substantiation in the presented data. Tyson's recent net income improvement suggests potential margin normalization, aligning with Opus's view that the $260M NI indicates an inflection point rather than a headfake. Opus rightly critiques the "losing 8% market share" narrative as unsupported since revenue remains flat. However, Opus's dismissal of the alt-protein threat as overstated requires caution; while Beyond Meat's current market cap is minor, the longer-term consumer trend towards plant-based proteins remains a potential risk.
Where I diverge from Opus is in the risk assessment of Tyson's balance sheet. The absence of clear debt figures in the data is troubling, as it obscures a full understanding of financial leverage. Historically, Tyson's debt has been substantial, and with thin interest coverage, this could pose a more significant risk than Opus suggests. Additionally, the insider transactions, while mostly neutral, do not provide confidence in internal bullishness, which should temper over-reliance on the positive Q1 margin print as a definitive cycle turn.
A careful skeptic would argue that both Opus and I might be underestimating the structural pressures Tyson faces from evolving consumer preferences and increasing regulatory burdens, which could erode long-term profitability. They might also question whether the recent margin recovery is sustainable in the face of potential macroeconomic headwinds and competitive pressures from alternative proteins and other market entrants.